Global Emerging Market Equities, Propitious Research

Wium Malan, CFA

Global Equity Analyst with 15+ years of experience as a Buy Side analyst covering companies in the Emerging and Developed markets.
Fundamental and Quantitative analysis on companies in the Internet, Telecommunication, Media, Technology, IT Services, Healthcare, Pharmaceutical and other Industrial sectors.
Idea generation focussed on Quality stocks, trading below their intrinsic Value, with sound Corporate Governance.

Global Emerging Market Equities

Alibaba: Accelerating Retail Sales, and a Depressed Comp Base, Bode Well for Near-Term Earnings

2023 High Conviction: JD.com to Benefit from Discretionary Spend Recovery, Margin Progress on Track

Independent, Fundamental Quantitative Research

Propitious Research

Fully independent, fundamental and quantitative equity research, focused on companies in the Telecommunication, Media, Technology, Internet and Healthcare sectors in the Global Emerging Markets. Idea generation focused on Quality stocks, trading below their intrinsic Value, with sound Corporate Governance.

Thematic (Sector/Industry)

<ul>
<li>The steady slowdown in Chinese retail sales growth rates since July 2021 has been a good leading indicator for changes eCommerce GMV and revenue growth rates.</li>
<li>April 2022 Chinese retail sales data (consumer goods were down -11.1%y/y and apparel down -23.2%y/y) is very concerning for the sector</li>
<li>From a company-specific perspective, it still seems as though near-term sell-side expectations remain too optimistic.</li>
</ul>


The steady slowdown in Chinese retail sales growth rates since July 2021 has been a good leading indicator for changes eCommerce GMV and revenue growth rates.
April 2022 Chinese retail sales data (consumer goods were down -11.1%y/y and apparel down -23.2%y/y) is very concerning for the sector
From a company-specific perspective, it still seems as though near-term sell-side expectations remain too optimistic.


Chinese Ecommerce: Chinese Retail Sales Data Indicates Further Near-Term Weakness